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Abstract 
Background 
Offering a drug-drug interaction (DDI) checker on-demand instead of computer-triggered alerts is a 
strategy to avoid alert fatigue. 
Objective 
The purpose was to determine the use of such an on-demand tool, implemented in the clinical 
information system for inpatients. 
Methods 
The study was conducted at the University Hospital Zurich, an 850-bed teaching hospital. The 
hospital-wide use of the on-demand DDI checker was measured for prescribers and consulting 
pharmacologists. The number of DDIs identified on-demand was compared to the number that would 
have resulted by computer-triggering and this was compared to patient-specific recommendations by 
a consulting pharmacist. 
Results 
The on-demand use was analyzed during treatment of 64,259 inpatients with 1,316,884 prescriptions. 
The DDI checker was popular with 9 consulting pharmacologists (648 checks/consultant). 
644 prescribing physicians used it infrequently (8 checks/prescriber). Among prescribers, internists 
used the tool most frequently and obtained higher numbers of DDIs per check (1.7) compared to 
surgeons (0.4). A total of 16,553 DDIs were identified on-demand, i.e. <10% of the number the 
computer would have triggered (169,192). A pharmacist visiting 922 patients on a medical ward 
recommended 128 adjustments to prevent DDIs (0.14 recommendations/patient), and 76% of them 
were applied by prescribers. In contrast, computer-triggering the DDI checker would have resulted in 
45 times more alerts on this ward (6.3 alerts/patient). 
Conclusions 
The on-demand DDI checker was popular with the consultants only. However, prescribers accepted 
76% of patient-specific recommendations by a pharmacist. The prescribers’ limited on-demand use 
  
indicates the necessity for developing improved safety concepts, tailored to suit these consumers. 
Thus, different approaches have to satisfy different target groups.  
  
Background 
Drug-drug interactions (DDIs) are an important cause of adverse drug events leading to increased 
morbidity and mortality.[1-3] As prescribing errors and resulting DDIs are potentially preventable, 
computerized physician order entry (CPOE) in combination with clinical decision support (CDS) offers 
an opportunity to minimize prescription errors.[4] 
However, excessive alerts of limited clinical significance induce alert fatigue.[5, 6] Hence, computer-
triggered safety alerts are often ignored by prescribers.[7] Users are more likely to accept warning 
messages if the alerting system features enhanced usability.[8] In particular, systems with improved 
acceptance are characterized by both, providing high quality of knowledge and presenting the 
messages in a user-friendly manner, including detailed advice.[9] 
To prevent overriding, one recent study investigated electronic hard stop alerts implemented in a 
CPOE system.[10] Although this intervention had a high impact on prescribing, the hard stop alerts 
induced clinically significant treatment delays in some patients. Another approach to minimize 
insignificant warnings recently suggested by Phansalkar et al. is a set of 15 high priority DDIs, for 
which alerts should be displayed in all electronic health records.[11] 
Automatically provided, workflow integrated CDS has been shown to be an advantage in successful 
systems.[12] However, that approach does not consider the burden of excessive automated alerts 
interfering with the workflow.[5] An on-demand DDI checker might offer an alternative to computer-
triggered DDI alerts. 
Tamblyn et al.[7] studied on-demand vs. computer-triggered prescription warnings in a user group of 
28 primary care physicians. They concluded that both approaches were unable to reduce the 
prevalence of prescribing problems in primary care. 
The clinical information system (CIS; Kisim, Cistec AG, Zurich, Switzerland) of the University Hospital 
Zurich has implemented an on-demand DDI checker without providing computer-triggered DDI alerts. 
To our knowledge, the use of an on-demand DDI checker integrated in a CIS for inpatients has not 
been analyzed so far. 
The purpose of this study was to assess the use of the DDI checker by (i) measuring the hospital-
wide use of the on-demand checker by both, prescribers and consulting pharmacologists, 
  
(ii) comparing the number of DDIs identified on-demand with the number that would have resulted by 
computer-triggering and (iii) comparing the computer-triggered DDI alerts to patient specific 
recommendations by a consulting pharmacist at ward rounds. 
Methods 
Study Design 
The DDI checker was retrospectively analyzed. Data were obtained during 90 weeks, from 4/12/2010 
(first activation of the on-demand checker) to 1/1/2012. The local research ethics committee approved 
the analyses, and patient consent was waived. 
Hospital 
The University Hospital Zurich is a teaching hospital covering all specialties, including a total of 850 
beds. All data are derived from inpatient care. 
DDI Knowledge Base 
DDIs were identified using a commercially available knowledge base (galdat/hospINDEX, e-mediat 
AG, Berne, Switzerland – deduced from ABDATA, Werbe- und Vertriebsgesellschaft Deutscher 
Apotheker, Eschborn, Germany) including comprehensive information on drug classes and agents 
approved in Switzerland. Both, DDIs increasing and decreasing therapeutic effects are covered.[13] 
This knowledge base is implemented in the CIS and categorizes the DDIs by 6 levels of severity 
(referred to as ‘tiering’ [14]; cf. table I), based on the Operational Classification of Drug Interactions 
(ORCA).[15] Level 1 DDIs are considered most severe. 
Clinical Information System 
Since late 2009, inpatient care is managed via CIS on all wards of the University Hospital Zurich 
except for intensive care units. All medication orders are entered by CPOE. The system offers several 
CDS functions, involving medication and laboratory data.[16] The knowledge base and front-end of 
the DDI checker are integrated components of the CIS. 
  
User Groups 
There are two distinct groups of users: (i) The prescribers and (ii) the consultants. 
(i) The prescribing physicians were categorized on the one hand according to specialty (internists, 
surgeons, other prescribers) and on the other hand according to professional experience 
(students & interns, residents, senior physicians). (ii) Consultants were non-prescribing 
pharmacologists and pharmacists. 
DDI Checker 
Prescribers and consultants of the University Hospital Zurich including the hospital-associated 
cantonal pharmacy can independently screen on-demand for DDIs, either during order entry 
(mode 1), while reviewing the patient chart (mode 2) or before printing prescriptions and reports 
(mode 3). 
In mode 2, the on-demand tool checks the prescribed medication for DDIs within the time frame 
displayed on screen. Depending on the definition of workflow integration, the studied tool may be 
considered as integrated, since two mouse clicks within the electronic patient chart are sufficient to 
start the DDI checker. 
The service provided by the checker consists of a tiered list of DDIs identified in the patient’s drug 
orders. The DDIs are sorted by severity level in ascending order, thus displaying the most severe 
DDIs uppermost. The majority of DDI reports does neither suggest alternative therapies nor provide 
concise, specific management recommendations. The DDI checker and its underlying knowledge 
base do not consider patient parameters. 
Time and mode of activation of the DDI checker, the user name and the number of identified DDIs 
were logged. The number of users was calculated by counting any user screening prescriptions for 
DDIs at least once. 
A user could customize the severity level up to which DDIs should be displayed. This limit was logged 
also. However, an analysis of the logs showed that the default setting (i.e. level 4) was changed by 
users in less than 1%. At ‘level 4’ preset, the 4 most important levels of severity (levels 1-4) are 
  
displayed, whereas reports on DDIs of level 5 and 6 remain hidden. With just one additional mouse 
click all DDIs (levels 1-6) are listed, tiered by severity. 
Consulting Pharmacist 
The impact of a consulting service on DDIs was evaluated in a medical ward by a consulting 
pharmacist, visiting a total of 922 patients at weekly rounds. The clinical significance of an identified 
DDI in the context of a patient’s condition was taken into account by this consultant. If indicated, the 
pharmacist recommended a time-displaced administration, intensified monitoring, substitution of a 
drug agent, dose adjustments or discontinuation of a specific drug. The pharmacist collected data 
about recommendations applied by internists in charge. 
In some cases the pharmacist also used other knowledge bases in addition to the implemented one 
and reviewed literature for further analysis of the specific situation. These findings are not represented 
in the proprietary knowledge base implemented in the CIS (cf. table II, ‘n.r.’). 
Overall Number of DDIs 
DDIs were retrospectively identified for pairs of concurrently prescribed drugs using the most recent 
version of the DDI knowledge base available at that time (February 2012). Replacing agents among 
the same drug class associated with the same DDI were counted as a single prescription (referred to 
as ‘class-class interactions’ [17]). Prescriptions for time periods spaced for less than 24 h were 
merged to avoid overestimated DDI numbers. Changes in dosing were not additionally considered, 
i.e. were counted as a single DDI. 
All DDIs independently identified by prescribers and pharmacologists due to the on-demand DDI 
checker are part of the total number of DDIs retrospectively identified by screening all prescriptions of 
all inpatients. Further, the DDIs identified by the knowledge base for the medical ward studied in 
greater detail (cf. table II, levels 1-6) result from the same algorithm used to perform the overall 
analysis and is therefore an inherent part of the total number of DDIs. 
Statistical Analyses 
Chi-square tests of independence were used for statistical analysis of frequencies in contingency 
tables. Differences in the frequencies of on-demand use between residents and other groups of 
  
prescribers were analyzed by the Kruskal-Wallis rank sum test. The p-levels of ≤0.05 were considered 
statistically significant. Data analysis and statistical tests were performed using the software 
EpiData V2.2.1.171 (EpiData Association, Odense, Denmark). 
Results 
Hospital-Wide Use of On-Demand DDI Checker 
Users screened prescriptions 10,828 times (120 checks/week), and a total of 16,553 DDIs were 
identified on-demand (1.5 DDIs/check). Prescriptions were checked by 653 users, including 644 
prescribing physicians (8 checks per prescriber). By far the most frequent users were 
9 pharmacologists screening for DDIs in preparation for their consulting service, but not personally in 
charge of prescribing medication (648 checks per consultant). Thus, total use of the DDI checker was 
higher by consultants (54%) compared to prescribers (internists 28%, surgeons 8%, other prescribers 
10%) (Fig. 1). 
Prescribing residents used the tool more often than other groups of prescribers (11.1 checks per 
resident vs. 4.3 checks per senior physician and 2.4 checks per student or intern; p<0.0001) 
(table III). Among specialty and experience, the number of prescribing users did not significantly differ, 
however, the frequencies of use were different (p<0.0001). 
Surgeons and other prescribers checked mainly during order entry (mode 1) whereas internists 
predominantly screened for DDIs while reviewing the patient chart (mode 2) (p<0.0001; table IV). 
Physicians in internal medicine obtained higher numbers of DDIs per check (1.7) compared to 
surgeons (0.4 DDIs/check). The number of medication orders for patients in wards of internal 
medicine and surgery averaged 19.0 and 12.8, respectively. 
DDIs Identified by the Knowledge Base 
A total of 1,316,884 prescriptions in 64,259 inpatients (ca. 20 drug orders/patient) were retrospectively 
analyzed. The proprietary knowledge base implemented in the CIS identified 169,192 DDIs, i.e. 
10-fold the number identified on-demand. If the knowledge base had automatically triggered all DDI 
alerts, on an average 2.6 DDI alerts per patient would have been displayed. Restricting the computer-
  
triggered DDI alerts to the 4 or 3 highest levels of severity would have resulted in 1.5 or 1.2 alerts per 
patient, respectively (table I). The 10 most frequent level 1 and level 2 DDIs identified by the 
knowledge base accounted for 4,589 DDIs (table V). 
Patient-Specific Recommendations by a Pharmacist 
On a medical ward, a consulting pharmacist joined once a week internists visiting their patients. If 
indicated, the pharmacist suggested specific modifications to minimize the risk of potentially harmful 
DDIs. 
The pharmacist made only 128 recommendations for the 922 inpatients visited 
(0.14 recommendations/patient) (table II). In contrast, computer-triggering the DDI checker would 
have generated 6.3 alerts/patient on this ward (7,902 DDIs/1,263 patients), i.e. the number of alerts 
would have increased by a factor of 45. 
However, in 97 of the 128 cases, these suggestions were applied by the physicians in charge, either 
as a time-displaced administration (34% of applied recommendations), intensified monitoring (24%), 
substitution of a drug agent (20%), dose adjustments (13%) or discontinuation of a specific drug (9%). 
These order changes were implemented in 81% immediately, in 13% the next day and in 6% within a 
week. Thus, the acceptance of the pharmacist’s recommendations according to the decisions made 
by the physicians in charge of the patient was 76%. 
The fraction of pharmacist’s recommendations per number of DDIs identified by the knowledge base 
correlated with the severity levels (p<0.0001), i.e. the higher the DDI severity according to the tiered 
knowledge base, the higher was the likelihood of a recommendation by the consultant (table II). 
Discussion 
Frequent computer-triggered DDI alerts of low clinical significance induce alert fatigue and therefore 
minimize the impact of CDS systems.[5, 6] Offering a DDI checker as an on-demand service is a 
strategy to avoid alert fatigue. Surprisingly, this DDI checker integrated in the CIS of a teaching 
hospital was predominantly used by the few consulting pharmacologists. In contrast, we observed a 
quite limited on-demand use by the large number of physicians in charge of prescription. However, 
  
the acceptance of a patient-adapted service to avoid DDIs provided by a consulting pharmacist at 
ward rounds achieved 76%. 
All professionals using the on-demand tool received identically presented DDI lists, tiered by severity 
level, in the majority of the DDI reports lacking specific management recommendations. On the one 
hand, inexperienced prescribers may feel uncertain about modifying established medication orders, 
particularly in the absence of recommendations for alternative therapies. On the other hand, senior 
physicians may disagree with the clinical significance of the reported DDIs since patient parameters 
and context were not considered by the DDI checker. Nevertheless, the high use of the on-demand 
DDI checker in the consulting pharmacologists group suggests that these specialists faced a 
convenient tool, generating DDI lists and supporting the preparation of ward rounds and 
consultations. 
The fact that internists found more DDIs per check than surgeons is in line with other studies [18], 
presenting higher numbers of prescribed drugs per patient in wards of internal medicine, similar to our 
findings. Internists predominantly screened for DDIs while reviewing the patient chart (mode 2) in 
order to overview the concurrent drug therapies frequently administered to multimorbid patients. 
As early as 1977, Morrell et al.[19] investigated an automated service involving a computer in the 
hospital pharmacy sending reports to prescribers when DDIs had been detected. The authors stated 
that the service was most useful for medical students and interns, because of their inexperience, their 
direct engagement in patient care and the importance of drug therapy in medical patients. However, 
the survey of the users revealed the “unduly repetitive”[19] nature of the reporting service as the 
major problem, a finding that is still valid due to the poor signal-to-noise ratio of comprehensive DDI 
information.[20, 21] 
Despite tremendous improvements in hardware and software seen in recent years, clinicians are 
frustrated by the dominance of false positive DDI reminders due to the shortcomings of the available 
knowledge bases. There are limited opportunities to safely turn off frequently overridden alerts.[22] 
Successful strategies to improve the specificity may require more sophisticated algorithms, e.g. by 
considering renal insufficiency, or upper dose limits for statins deduced from pharmacokinetic 
studies.[23, 24] Although minimizing the number of alerts is an approach to increase the specificity, 
  
DDI compendia show little consensus about the most severe DDIs.[25] However, an expert panel 
recently suggested a set of 15 important DDIs for which all CIS should display alerts.[11] 
Limitations of our study include lack of a sensitivity analysis of the knowledge base implemented to 
identify DDIs. Though a comprehensive knowledge base should reach a high sensitivity, 
24 recommendations by the pharmacist to prevent DDIs were not included in the knowledge base (cf. 
table II). Worth mentioning are 7 of these 24 recommendations concerning liquid paraffin as a laxative 
interfering with fat-soluble agents, yet, lipophilicity is not represented within the knowledge base. The 
pharmacist’s recommendations have not been validated by another specialist. Further, it is possible 
that some of the issues addressed by the pharmacist had already been identified on-demand by a 
prescriber, however, this was not verifiable in this retrospective analysis. Whether critical DDIs might 
have been missed if users infrequently searched for DDIs remains unknown because the checker did 
not log severity levels and identification numbers of interacting orders required for such an analysis. 
The comparison of the computer-triggered DDI alerts with the pharmacist’s recommendations is 
based on data from DDIs found in a group of 922 medical patients. That is a modest sample size and 
in other specialties than internal medicine numbers of automated alerts could differ. Nevertheless, our 
data are consistent with previous reports, observing limited sensitivity and poor specificity of 
knowledge bases.[26, 27] 
Developing algorithms that provide patient-specific recommendations is a major challenge. Most 
implementations neither do sufficiently address patient conditions nor do they generate detailed 
recommendations. Further research is necessary to adequately support prescribing physicians. 
Decisions taken on DDIs in the presence of a pharmacist consultant during clinical visits may or may 
not be the gold standard. However, they do represent a quality controlled approach on the 
management of DDIs, documenting a quite limited need for changing orders, i.e. in less than 10% of 
the patients (79 of 922, on the evaluated ward). The acceptance of 76% of the pharmacist’s 
recommendations and their immediate implementation by the prescribing internists in 81% underline 
the practicability and clinical significance of the pharmacist’s service. 
The pharmacist’s recommendations correlated with the levels of severity provided by the knowledge 
base. Categorizing DDIs by severity is necessary but not sufficient to solve the problem.[7, 25, 28] 
Drug combinations associated with DDIs considered severe are sometimes ordered by prescribers 
  
because of a well-known DDI and not despite. E.g. the most frequent level 1 DDI observed was 
related to the treatment of hypokalemia by ordering potassium sparing diuretics and potassium 
supplement (cf. table V), generating a DDI report warning against the risk of hyperkalemia.[18] Thus, 
before reporting a DDI, the condition of the patient should be taken into account. Such concepts may 
offer promising strategies to improve the specificity of computer-triggered alerts.[11, 20, 27, 29] 
Among the 10 most frequent level 1 and level 2 DDIs identified by the knowledge base (cf. table V), 
the “prescription” ethanol needs further explanation. Ethanol may be used in pharmaceutical 
formulations as an additive. Several distinct drugs containing ethanol are involved in the 115 
interactions identified by the knowledge base. Since these drugs contain only small quantities of 
ethanol, the sedative effect described for the concurrent administration with neuroleptics may be less 
significant than suggested by the severity level 2. Triggering warnings for DDIs of little clinical 
significance would contribute to alert fatigue. 
DDI reports should be concise, user friendly and customizable.[29] Personal options such as “remind 
me in one week” and “don’t show this message again” could be part of this approach. In order to 
attract prescribers, DDI reports providing alternative management recommendations have been 
advocated.[30] 
Customer adapted tailoring of DDI alerts is of importance as documented by the highly diverse 
frequency of use by prescribers and consultants. A “one fits all” DDI warning system may not meet 
the needs of all user groups: On the one hand, consultants are interested in a system providing high 
sensitivity, and on the other hand, prescribers are interested in patient-specific support including 
detailed advice.[9] 
Conclusions 
The on-demand DDI checker was popular with the pharmacologists. In contrast, prescribing 
physicians used the tool infrequently. However, prescribers accepted professional advice to avoid 
DDIs, as documented by the substantial impact of patient-specific recommendations. The prescribers’ 
limited on-demand use indicates the necessity for developing improved safety concepts, tailored to 
suit these consumers. Thus, different approaches may have to satisfy the needs of different target 
groups.  
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Figure Legends 
 
 
Fig. 1: (a) Number of on-demand DDI checks triggered by prescribers and consulting 
pharmacologists. (b) Number of prescribers and consulting pharmacologists using the DDI checker. 
 
  
  
Table I. DDIs retrospectively identified and tiered by the knowledge base in 64,259 inpatients 
Level of severity (explanation) 
N° of identified 
DDIs 
1 (contraindicated) 1,196 
2 (contraindicated as precaution) 4,674 
3 (monitoring or adaptations required) 72,046 
4 
(monitoring or adaptations if risk factors are 
present) 
18,827 
5 (monitoring as precaution) 70,580 
6 (usually no action required) 1,869 
Total 169,192 
 
  
  
Table II. Number of DDIs identified by the knowledge base and pharmacist’s recommendations in a medical ward 
 
Knowledge base 
 
Ward’s consulting pharmacist 
 
Ward’s prescribing internists 
 
A
a
 
 
B
b
 B / A 
 
C
c
 C / A 
 
C / B 
Level of 
severity
d
 
Identified DDIs 
 
Recommendations 
Recommendations/ 
Identified DDIs  
Applied 
recommendations 
Applied recommen-
dations/Identified 
DDIs 
 
Recommendations 
applied by 
prescribers 
1 23 
 
6 26.1% 
 
6 26.1% 
 
100% 
2 171 
 
15 8.8% 
 
14 8.2% 
 
93.3% 
3 2,866 
 
62 2.2% 
 
47 1.6% 
 
75.8% 
4 816 
 
14 1.7% 
 
10 1.2% 
 
71.4% 
5 3,998 
 
7 0.2% 
 
6 0.2% 
 
85.7% 
6 28 
 
0 0% 
 
0 0% 
 
- 
    
 
    
 
    
 
  
n.r.
e
 - 
 
24 - 
 
14 - 
 
58.3% 
    
 
    
 
    
 
  
Total 7,902 
 
128 1.6% 
 
97 1.2%   75.8% 
 
a
 Number of DDIs identified by the knowledge base. 
b
 Number of recommendations by a consulting pharmacist to prevent DDIs. 
c
 Number of pharmacist’s recommendations applied by internists in charge. 
d
 For explanations of the levels of severity cf. table I. 
e
 Findings of the pharmacist not represented within the implemented knowledge base. 
 
  
  
Table III. Number of checks triggered on-demand, number of prescribers and average number of checks per prescriber, by position and specialty of prescribers 
 
All prescribers 
 
Internists 
 
Surgeons 
 
Other prescribers 
                
 
N
° 
o
f 
c
h
e
c
k
s
 
N
° 
o
f 
u
s
e
rs
 
N
° 
o
f 
c
h
e
c
k
s
/ 
N
° 
o
f 
u
s
e
rs
 
 
N
° 
o
f 
c
h
e
c
k
s
 
N
° 
o
f 
u
s
e
rs
 
N
° 
o
f 
c
h
e
c
k
s
/ 
N
° 
o
f 
u
s
e
rs
 
 
N
° 
o
f 
c
h
e
c
k
s
 
N
° 
o
f 
u
s
e
rs
 
N
° 
o
f 
c
h
e
c
k
s
/ 
N
° 
o
f 
u
s
e
rs
 
 
N
° 
o
f 
c
h
e
c
k
s
 
N
° 
o
f 
u
s
e
rs
 
N
° 
o
f 
c
h
e
c
k
s
/ 
N
° 
o
f 
u
s
e
rs
 
students & 
interns 
342 141 2.4 
 
177 72 2.5 
 
92 44 2.1 
 
73 25 2.9 
residents 4,073 367 11.1 
 
2,426 167 14.5 
 
745 118 6.3 
 
902 82 11 
senior 
physicians 
579 136 4.3 
 
425 62 6.9 
 
51 33 1.5 
 
103 41 2.5 
Total 4,994 644 7.8 
 
3,028 301 10.1 
 
888 195 4.6 
 
1,078 148 7.3 
 
  
  
Table IV. Number of on-demand DDI checks by selected mode and specialty 
 
All users 
Fraction 
of total  
Internists 
Fraction 
of total  
Surgeons 
Fraction 
of total  
Other 
prescribers 
Fraction 
of total  
Consulting 
pharmacologists 
Fraction 
of total 
Mode 
1
a
 
2,262 20.9% 
 
738 24.4% 
 
689 77.6% 
 
829 76.9% 
 
6 0.1% 
Mode 
2
b
 
7,551 69.7% 
 
1,472 48.6% 
 
93 10.5% 
 
159 14.7% 
 
5,827 99.9% 
Mode 
3
c
 
1,015 9.4% 
 
818 27.0% 
 
106 11.9% 
 
90 8.3% 
 
1 0.0% 
Total 10,828 
  
3,028 
  
888 
  
1,078 
  
5,834 
 
 
a
 On-demand DDI checks during order entry. 
b
 Checks while reviewing patient chart. 
c
 Checks before printing prescriptions or reports. 
 
  
  
Table V. Hospital-wide top 10 most frequent level 1 and level 2 DDIs identified by the knowledge base 
Level of 
severity 
Interacting class 1 Interacting class 2 
N° of 
occurren
ces 
2 Clopidogrel Proton pump inhibitors 942 
1 
Potassium 
supplement 
Potassium-sparing 
diuretics 
888 
2 QT-prolonging agents  
Droperidol, Pimozide, 
Sertindole, Thioridazine 
850 
2 QT-prolonging agents Antiarrhythmic agents 813 
2 Clopidogrel 
Enzyme inhibitors 
(CYP2C19) 
302 
2 Antiarrhythmic agents Antibiotics 287 
2 Levodopa Dopamine antagonists 150 
2 Opioid agonists 
Opioid-agonists/-
antagonists 
138 
2 Neuroleptics Ethanol
a
 115 
1 Statins Macrolide antibiotics 104 
 
a
 Pharmaceutical formulations containing ethanol as an additive. 
 
 
